conjunctivitis%20-%20viral
CONJUNCTIVITIS - VIRAL
Viral conjunctivitis is the inflammation of the conjunctiva of viral etiology.
Signs and symptoms include unilateral or bilateral eye redness, foreign body sensation and follicular conjunctival reaction.
It may be caused by adenovirus, herpes simplex or molluscum contagiosum.

Conjunctivitis - Viral Drug Information

Drug Information

Indication: Treatment & prevention of herpes simplex virus infections, genital herpes of skin & mucous membranes &...

Indication: Herpes simplex virus infections of skin & mucous membranes including initial & recurrent genital herpe...

Indication: Herpes simplex skin & mucous membrane infections including initial & recurrent genital herpes. Suppres...

Indication: Management of acute & chronic anterior uveitis, iridocyclitis, iritis & cyclitis, herpes zoster ophtha...

Indication: Relief of ocular irritation, congestion & treatment of allergic or inflammatory ocular conditions.

Indication: Temporary prevention of eye itching due to allergic conjunctivitis.

Indication: Allergic conjunctivitis.

Indication: Treatment & prophylaxis of herpes genitalis, treatment of herpes zoster, herpes simples & varicella (c...

Shinallerg
antazoline hydrochloride + tetryzoline hydrochlori...

Indication: Non-infectious irritative conjunctivitis, allergic-inflammatory conjunctival affections, hay fever & conju...

Indication: Varicella-zoster viral infections. Skin & mucous membrane infections due to herpes simplex virus. Prophyla...

1  /  5
Editor's Recommendations
Most Read Articles
4 days ago
Supplementation with probiotics may have positive effects in patients with type 2 diabetes mellitus (T2DM), reports a recent meta-analysis.
Roshini Claire Anthony, 6 days ago

Frailty may indicate an increased risk of death from COVID-19, results of the COPE* study showed.

6 days ago
Regardless of treatment, serum hepcidin is elevated in patients with restless leg syndrome (RLS) and may act as a biomarker for this condition, a recent study has found.
Jairia Dela Cruz, 2 days ago
In the first year following percutaneous coronary intervention for acute coronary syndrome, ticagrelor and prasugrel cuts the risk of gastrointestinal (GI) bleeding by more than 30 percent compared with clopidogrel, as shown in a large real-world study.